network member

The University of Chicago Medicine Comprehensive Cancer Center

5841 South Maryland Avenue, Chicago, IL 60637

About Network Member

The University of Chicago Medicine Comprehensive Cancer Center, located in Chicago’s Hyde Park neighborhood, is committed to exploring and developing innovative ways to prevent and reduce cancer’s devastating effects through a collaborative research program involving more than 200 renowned researchers and physicians. UChicago’s Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in Illinois and has earned a reputation for excellence, innovation, and a commitment to addressing cancer from every angle. Seminal discoveries made at UChicago have stimulated the development and introduction of many of the cancer treatments used today. Many of the roots of chemotherapy, hormonal therapy, gene therapy, and bone marrow transplantation can be traced to UChicago. For example, Dr. Janet D. Rowley made many breakthroughs vital to understanding the relationships between genetics and cancer, and opened the door to effective targeted therapies for leukemias and lymphomas. This legacy of discovery drives our researchers to pursue breakthroughs that will lead to new and better cancer treatments. Together, we can #AnswerCancer. Website: uchicagomedicine.org/cancer/
Amanda Spratt
Currently Enrolling

HCRN-GU21-517

A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY)
Cancer areas:Prostate
Moores Cancer Center at UC San Diego Health
The University of Chicago Medicine Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Currently Enrolling

TBCRC046

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (“PALAVY”)
Cancer areas:Breast
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Penn Medicine Abramson Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Currently Enrolling

TBCRC047

Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study
Cancer areas:Breast
Dana-Farber Cancer Institute
Duke Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
University of Alabama at Birmingham Comprehensive Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Enrollment Closed

HCRN-BRE18-334

A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
Cancer areas:Breast
Advocate Aurora Research Institute (Illinois)
Aurora Health Care
Froedtert & the Medical College of Wisconsin
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Miami Cancer Institute at Baptist Health, Inc.
Novant Health Oncology Specialists
The University of Chicago Medicine Comprehensive Cancer Center
University of Alabama at Birmingham Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
UT Health San Antonio MD Anderson Cancer Center
Enrollment Closed

TBCRC044

A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Cancer areas:Breast
Dana-Farber Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
UPMC Hillman Cancer Center
Vanderbilt-Ingram Cancer Center